Follow
'The majority of vaccines licenced to date have been assessed for efficacy against clinical disease endpoints in randomised controlled trials (RCT’s), this approach is viewed as the gold standard method to demonstrate the efficacy data required by regulators for licensure. However, this traditional approach is not always feasible in certain situations.'
